Exact Mass: 283.1321

Exact Mass Matches: 283.1321

Found 34 metabolites which its exact mass value is equals to given mass value 283.1321, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

brevianamide F

C16H17N3O2 (283.1321)

A pyrrolopyrazine that is hexahydropyrrolo[1,2-a]pyrazine-1,4-dione bearing an indol-3-ylmethyl substituent at position 3 (the 3S,8aS-diastereomer, obtained by formal cyclocondensation of L-tryptophan and L-proline). Brevianamide F (Cyclo(L-Pro-L-Trp)) is a mycotoxin isolated from Colletotrichum gloeosporioides, with antibacterial activity. Brevianamide F shows potent PI3Kα inhibitory activity with an IC50 of 4.8 μM[1][2].

Amonafide

11-amino-3-[2-(dimethylamino)ethyl]-3-azatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaene-2,4-dione

C16H17N3O2 (283.1321)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D007364 - Intercalating Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors

Dazmegrel

3-{3-[(1H-imidazol-1-yl)methyl]-2-methyl-1H-indol-1-yl}propanoic acid

C16H17N3O2 (283.1321)

C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor

Exact Mass: 283.1321

Exact Mass Matches: 283.1321

brevianamide F

Amonafide

Dazmegrel

Tryptophandehydrobutyrine diketopiperazine

8-Hydroxyergine

8-Hydroxyerginine

Ethyl 5-amino-4-cyano-3-methyl-1-(4-methylphenyl)-1H-pyrrole-2-carboxylate

3-(1H-indol-3-ylmethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione

1-[2-(4-METHOXY-PHENOXY)-ETHYL]-1H-BENZOIMIDAZOL-2-YLAMINE

Acetanilide,2,2-iminobis- (8CI)

3-[2-(2-METHOXY-PHENYL)-PYRAZOLO[1,5-A]PYRIMIDIN-6-YL]-PROPAN-1-OL

1-(2-NITROBENZYL)PIPERAZINEDIHYDROCHLORIDE

2-amino-n-furan-2-ylmethyl-3-(1h-indol-3-yl)-propionamide

2-Methoxy-6-[[(1-methylbenzimidazol-2-yl)amino]methyl]phenol

4-Phenyl-2-(piperidin-1-yl)pyrimidine-5-carboxylic acid

5-Methoxy-2-[[(1-methyl-2-benzimidazolyl)amino]methyl]phenol

Amonafide

Dazmegrel

3-(1H-indol-3-ylmethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione

3-(5-Tert-butyl-1,2,4-oxadiazol-3-ylidene)-7-methyl-2-quinolinone

1-(1-Benzotriazolyl)-3-(2-methylphenoxy)-2-propanol

2-Amino-9-ethyl-3-pyrido[2,3-b]indolecarboxylic acid ethyl ester

4-[acetyl(methyl)amino]-N-(2-aminophenyl)benzamide

Cyclo(Trp-Pro)

2-(n-hydroxyimino)-3-[7-(3-methylbuta-1,3-dien-1-yl)-1h-indol-3-yl]propanamide

(3r,8as)-1-hydroxy-3-(1h-indol-3-ylmethyl)-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one

(3z)-3-ethylidene-5-hydroxy-6-(1h-indol-3-ylmethyl)-1-methyl-6h-pyrazin-2-one

2-hydroxy-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),3,9,12,14-pentaene-4-carboximidic acid

(3e,6s)-3-ethylidene-5-hydroxy-6-(1h-indol-3-ylmethyl)-1-methyl-6h-pyrazin-2-one

(2z)-2-(n-hydroxyimino)-3-{7-[(1e)-3-methylbuta-1,3-dien-1-yl]-1h-indol-3-yl}propanimidic acid

(2s,7r)-2-hydroxy-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),3,9,12,14-pentaene-4-carboximidic acid

2-{[(2-phenylethyl)-c-hydroxycarbonimidoyl]amino}benzenecarboximidic acid

4-hydroxy-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboximidic acid

1-hydroxy-3-(1h-indol-3-ylmethyl)-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one